2021
DOI: 10.1016/j.expneurol.2021.113762
|View full text |Cite
|
Sign up to set email alerts
|

Ruxolitinib exerts neuroprotection via repressing ferroptosis in a mouse model of traumatic brain injury

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
20
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 37 publications
(27 citation statements)
references
References 50 publications
2
20
0
Order By: Relevance
“… 12 3F3-FMA, as well as other anti-TfR1 antibodies, exhibits an increase in total and membrane-localized fluorescence when used to stain cells undergoing ferroptosis in culture (compared to vehicle-treated control cells). TfR1 has been used to identify the occurrence of ferroptosis in traumatic brain injury 13 and myocardial ischemia/reperfusion injury, 14 among other uses. Thus, TfR1 serves as a biomarker to facilitate the identification of ferroptosis in cell and tissue contexts.…”
Section: Introductionmentioning
confidence: 99%
“… 12 3F3-FMA, as well as other anti-TfR1 antibodies, exhibits an increase in total and membrane-localized fluorescence when used to stain cells undergoing ferroptosis in culture (compared to vehicle-treated control cells). TfR1 has been used to identify the occurrence of ferroptosis in traumatic brain injury 13 and myocardial ischemia/reperfusion injury, 14 among other uses. Thus, TfR1 serves as a biomarker to facilitate the identification of ferroptosis in cell and tissue contexts.…”
Section: Introductionmentioning
confidence: 99%
“…In a previous study from our group [ 23 ], iron deposition was observed to increase 3–7 days after TBI in a mouse model. We [ 24 ] also found that iron deposition in the injured cortex was significantly higher than that in control cortex 21 days after TBI. Furthermore, we demonstrated that the iron metabolism pathway-related proteins TfR1, FPN, FTH, and FTL were temporally expressed in injured cortex, with TfR1 and FPN expression peaking 6–12 h after TBI and FTH and FTL expression peaking 3–7 days after TBI [ 23 , 24 ].…”
Section: The Ferroptosis Regulatory Pathway and Ferroptosis Activatio...mentioning
confidence: 91%
“…We [ 24 ] also found that iron deposition in the injured cortex was significantly higher than that in control cortex 21 days after TBI. Furthermore, we demonstrated that the iron metabolism pathway-related proteins TfR1, FPN, FTH, and FTL were temporally expressed in injured cortex, with TfR1 and FPN expression peaking 6–12 h after TBI and FTH and FTL expression peaking 3–7 days after TBI [ 23 , 24 ]. These findings suggest that the amount of iron deposition and expression of iron metabolism pathway-related proteins in the injured area correlate with the time since TBI.…”
Section: The Ferroptosis Regulatory Pathway and Ferroptosis Activatio...mentioning
confidence: 91%
“…MiR-212-5p attenuates neuronal ferroptosis after TBI by targeting PTGS2 [141]. Ruxolitinib was found to protect against neuronal ferroptosis in a mouse TBI model [142]. Ferristatin II, an iron uptake inhibitor, prevents neuronal ferroptosis after TBI [143], while tetrandrine ameliorates TBI by regulating autophagy to reduce ferroptosis [144].…”
Section: Traumatic Brain Injurymentioning
confidence: 99%